AC Immune SA (ACIU)
2.395
-0.02
(-1.03%)
USD |
NASDAQ |
May 03, 14:18
AC Immune Price to Book Value: 1.238 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 1.251 |
| May 01, 2024 | 1.293 |
| April 30, 2024 | 1.282 |
| April 29, 2024 | 1.241 |
| April 26, 2024 | 1.215 |
| April 25, 2024 | 1.184 |
| April 24, 2024 | 1.226 |
| April 23, 2024 | 1.231 |
| April 22, 2024 | 1.251 |
| April 19, 2024 | 1.220 |
| April 18, 2024 | 1.231 |
| April 17, 2024 | 1.251 |
| April 16, 2024 | 1.267 |
| April 15, 2024 | 1.303 |
| April 12, 2024 | 1.417 |
| April 11, 2024 | 1.412 |
| April 10, 2024 | 1.448 |
| April 09, 2024 | 1.448 |
| April 08, 2024 | 1.448 |
| April 05, 2024 | 1.422 |
| April 04, 2024 | 1.422 |
| April 03, 2024 | 1.448 |
| April 02, 2024 | 1.396 |
| April 01, 2024 | 1.412 |
| March 28, 2024 | 1.531 |
| Date | Value |
|---|---|
| March 27, 2024 | 1.567 |
| March 26, 2024 | 1.469 |
| March 25, 2024 | 1.500 |
| March 22, 2024 | 1.588 |
| March 21, 2024 | 1.629 |
| March 20, 2024 | 1.683 |
| March 19, 2024 | 1.738 |
| March 18, 2024 | 1.810 |
| March 15, 2024 | 1.810 |
| March 14, 2024 | 1.722 |
| March 13, 2024 | 1.919 |
| March 12, 2024 | 1.815 |
| March 11, 2024 | 1.774 |
| March 08, 2024 | 1.961 |
| March 07, 2024 | 2.012 |
| March 06, 2024 | 2.012 |
| March 05, 2024 | 2.049 |
| March 04, 2024 | 1.888 |
| March 01, 2024 | 1.997 |
| February 29, 2024 | 1.878 |
| February 28, 2024 | 2.028 |
| February 27, 2024 | 1.966 |
| February 26, 2024 | 1.955 |
| February 23, 2024 | 1.784 |
| February 22, 2024 | 1.701 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7361
Minimum
Dec 22 2022
3.597
Maximum
Dec 29 2023
1.668
Average
1.583
Median
Price to Book Value Benchmarks
| CRISPR Therapeutics AG | 2.529 |
| Addex Therapeutics Ltd | 6.662 |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | 0.6522 |
| MoonLake Immunotherapeutics | 5.706 |
Price to Book Value Related Metrics
| Price | 2.395 |
| Earnings Yield | -29.62% |
| Market Cap | 236.86M |